Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02712
Species: Homo sapiens
Position : chr2:11633299-11641134
Year: 2018
Title: Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: Breast Cancer
PMID:  29378668
MONDO: MONDO:0007254
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MCF-7
CVCL ID: CVCL_0031
Experiment Type: TF-binding/chromatin assay; Chromatin interaction assay; Endogenous enhancer perturbation; Disease-associated enhancer analysis
High Throughput Method: ChIP-seq
Low Throughput Method: CRISPR-Cas9 targeted editing/deletion; ChIP-qPCR/ChIP; 3C; RT-qPCR/qPCR
About Target Gene
Target gene : GREB1
About TF
TF name : TDG
About Regulatory State
Regulatory State : Inactive
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TDG Cleavage of the damaged pyrimidine reactome 8
TDG Displacement of DNA glycosylase by APEX1 reactome 9
TDG Recognition and association of DNA glycosylase with site containing an affected pyrimidine reactome 8
TDG SUMOylation of DNA damage response and repair proteins reactome 76
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer